Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 150 clinical trials for: 150 miles

Recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
  • Recruiting
NCT06966453
Sex: All
Age: 18+
Locations: 68
View study
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  • Recruiting
NCT05156398
Sex: All
Age: 6 - 17
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
  • Recruiting
NCT07144280
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
  • Recruiting
NCT07013474
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  • Recruiting
NCT06641466
Sex: Female
Age: 18 - 45
Locations: 50
View study
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  • Recruiting
NCT06807268
Sex: All
Age: 6 - 11
Locations: 31
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
  • Recruiting
NCT06137742
Sex: All
Age: 18 - 65
Locations: 50
View study
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  • Recruiting
NCT07028853
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
  • Recruiting
NCT05317416
Sex: All
Age: 18+
Locations: 52
View study
...